Stemcell Technologies, Inc. licenses Geron Intellectual Property to develop media and matrices for stem cell growth

Geron has received a license to Stemcell Technologies under Geron intellectual property relating to primate pluripotent stem cells, including human embryonic stem cells.

The non-exclusive license provides Stemcell with rights under certain Geron patents to develop, manufacture and sell cell culture media and matrix surfaces for research use only.

Geron will receive license payments and is entitled to royalties on sales of products developed under the license.

Financial terms of the deal were not disclosed.

The initial product covered by the license is STEMCELL’s mTeSR 1 medium, which became available to the research community last June.

mTeSR 1 is the first commercially available feeder-independent, serum-free, defined maintenance medium for human embryonic stem cells.